025IC - Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach Oncology: Bladder/Urothelium/Urethra

Saturday, April 29, 2023

7:30 AM – 9:30 AM CST

Location: S102C

Instructional Course Director(s)

jH

jeff Holzbeierlein, MD

Physician in Chief
University of Kansas Health System

Instructional Course Faculty(s)

Michael Cookson, MD,MHA

Professor and Chair
University of Oklahoma
TM

Timothy Masterson, MD,FACS (he/him/his)

Indiana University School of Medicine
sanjay Patel, MD

Associate Professor
University of Oklahoma Health Sciences Center

Course Description: The course director will select six real cases from his own practice that represent challenging cases in
bladder cancer and present them to his panelists. The panelists will review the available literature and formulate a treatment plan based upon the guidelines and published literature. The course director will then present the actual patient outcome and readdress the panelists with follow-up problems and questions to illustrate the many unique aspects of dealing with these patients.

Learning Objectives:

Identify low-, intermediate- and high-risk non-muscle invasive bladder cancer.
Recommend treatment for non-muscle invasive bladder cancer based on risk stratification.
Describe the management of invasive bladder cancer including surgery, neoadjuvant and adjuvant chemotherapy, and bladder preservation strategies in patients with muscle invasive bladder cancer. This will include chemotherapy indications and the role of immunotherapy in management.
Manage upper tract tumors, both low grade and high grade, including renal preservation when appropriate, neoadjuvant therapy when indicated and surgical management strategies.